MedWatch

Audientes fulfills 2021 resolution to make third Indian partnership

By signing an agreement with a third partner, hearing aid manufacturer Audientes has achieved its 2021 resolution and now looks ahead to fourth quarter revenue.

Steen Thygesen, CEO at Audientes | Photo: Audientes / PR

One of the big milestones has been reached.

This is how CEO at Audientes Steen Thygesen describes the fact that the company can announce that it has entered a third go-to-market partnership in India – the biggest market for Audientes's primary target group.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs